102 related articles for article (PubMed ID: 7837221)
21. Synthesis and docking studies of novel antitumor benzimidazoles.
Omar MA; Shaker YM; Galal SA; Ali MM; Kerwin SM; Li J; Tokuda H; Ramadan RA; El Diwani HI
Bioorg Med Chem; 2012 Dec; 20(24):6989-7001. PubMed ID: 23123017
[TBL] [Abstract][Full Text] [Related]
22. The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells.
Fahey K; O'Donovan L; Carr M; Carty MP; Aldabbagh F
Eur J Med Chem; 2010 May; 45(5):1873-9. PubMed ID: 20122765
[TBL] [Abstract][Full Text] [Related]
23. Terbenzimidazoles: influence of 2"-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons.
Kim JS; Yu C; Liu A; Liu LF; LaVoie EJ
J Med Chem; 1997 Aug; 40(18):2818-24. PubMed ID: 9288163
[TBL] [Abstract][Full Text] [Related]
24. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents.
Islam I; Skibo EB; Dorr RT; Alberts DS
J Med Chem; 1991 Oct; 34(10):2954-61. PubMed ID: 1920349
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Biological Evaluation of 2-Aminobenzothiazole and Benzimidazole Analogs Based on the Clathrodin Structure.
Montalvão S; Leino TO; Kiuru PS; Lillsunde KE; Yli-Kauhaluoma J; Tammela P
Arch Pharm (Weinheim); 2016 Feb; 349(2):137-49. PubMed ID: 26709468
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and cytotoxic activity of novel hexahydropyrrolo[2,3-b]indole imidazolium salts.
Zhou Y; Duan K; Zhu L; Liu Z; Zhang C; Yang L; Li M; Zhang H; Yang X
Bioorg Med Chem Lett; 2016 Jan; 26(2):460-465. PubMed ID: 26684853
[TBL] [Abstract][Full Text] [Related]
28. Studies on quinones. Part 46. Synthesis and in vitro antitumor evaluation of aminopyrimidoisoquinolinequinones.
Vásquez D; Rodríguez JA; Theoduloz C; Calderon PB; Valderrama JA
Eur J Med Chem; 2010 Nov; 45(11):5234-42. PubMed ID: 20828890
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxic activity of substituted luotonin A derivatives.
Dallavalle S; Merlini L; Beretta GL; Tinelli S; Zunino F
Bioorg Med Chem Lett; 2004 Dec; 14(23):5757-61. PubMed ID: 15501036
[TBL] [Abstract][Full Text] [Related]
30. Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.
Cindrić M; Jambon S; Harej A; Depauw S; David-Cordonnier MH; Kraljević Pavelić S; Karminski-Zamola G; Hranjec M
Eur J Med Chem; 2017 Aug; 136():468-479. PubMed ID: 28525845
[TBL] [Abstract][Full Text] [Related]
31. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
Benites J; Valderrama JA; Rivera F; Rojo L; Campos N; Pedro M; José Nascimento MS
Bioorg Med Chem; 2008 Jan; 16(2):862-8. PubMed ID: 17964791
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors.
Wang J; Wang X; Li H; Ji D; Li Y; Xu Y; Zhu Q
Bioorg Med Chem Lett; 2016 Aug; 26(16):4127-32. PubMed ID: 27353531
[TBL] [Abstract][Full Text] [Related]
33. Studies on quinones. Part 41: synthesis and cytotoxicity of isoquinoline-containing polycyclic quinones.
Valderrama JA; González MF; Pessoa-Mahana D; Tapia RA; Fillion H; Pautet F; Rodriguez JA; Theoduloz C; Schmeda-Hirschmann G
Bioorg Med Chem; 2006 Jul; 14(14):5003-11. PubMed ID: 16563773
[TBL] [Abstract][Full Text] [Related]
34. New selective cytotoxic diterpenylquinones and diterpenylhydroquinones.
Miguel Del Corral JM; Gordaliza M; Castro MA; Mahiques MM; Chamorro P; Molinari A; García-Grávalos MD; Broughton HB; San Feliciano A
J Med Chem; 2001 Apr; 44(8):1257-67. PubMed ID: 11312925
[TBL] [Abstract][Full Text] [Related]
35. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
[TBL] [Abstract][Full Text] [Related]
36. Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril.
Zhao Y; Pourgholami MH; Morris DL; Collins JG; Day AI
Org Biomol Chem; 2010 Jul; 8(14):3328-37. PubMed ID: 20523944
[TBL] [Abstract][Full Text] [Related]
37. Triple molecular target approach to selective melanoma cytotoxicity.
Skibo EB; Jamil A; Austin B; Hansen D; Ghodousi A
Org Biomol Chem; 2010 Apr; 8(7):1577-87. PubMed ID: 20237668
[TBL] [Abstract][Full Text] [Related]
38. Synthesis by radical cyclization and cytotoxicity of highly potent bioreductive alicyclic ring fused [1,2-a]benzimidazolequinones.
Lynch M; Hehir S; Kavanagh P; Leech D; O'Shaughnessy J; Carty MP; Aldabbagh F
Chemistry; 2007; 13(11):3218-26. PubMed ID: 17200920
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.
Stýskala J; Stýskalová L; Slouka J; Hajdúch M
Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
